Anlotinib for Hepatocellular Carcinoma

Clinical trial NCT04954521 · UNKNOWN

Trial details

NCT number: NCT04954521
Sponsor: People's Hospital of Guangxi Zhuang Autonomous Region
Status: UNKNOWN
Study type: OBSERVATIONAL

Liver Neoplasms

Start date: 2021-06-30
Primary completion: 2023-07-05
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.